Global Biopsy Devices Market

1 INTRODUCTION OF GLOBAL BIOPSY DEVICES MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BIOPSY DEVICES MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION
5.1 Breast Biopsy
5.2 Lung Biopsy
5.3 Colorectal Biopsy
5.4 Prostate Biopsy
5.5 Other Applications

6 GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT
6.1 Needle Based Biopsy Instruments
6.2 Core Biopsy Devices
6.3 Aspiration Biopsy Needles
6.4 Vacuum-Assisted Biopsy Devices
6.5 Procedure Trays
6.6 Localization Wires
6.7 Other Products

7 GLOBAL BIOPSY DEVICES MARKET, BY END USER
7.1 Hospitals
7.2 Academic and Research centers
7.3 Diagnostic and Imaging Canters

8 GLOBAL BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUES
8.1 Ultrasound-Guided Biopsy
8.2 Stereotactic-Guided Biopsy
8.3 MRI-Guided Biopsy
8.4 Other Guidance Techniques

9 GLOBAL BIOPSY DEVICES MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

10 GLOBAL BIOPSY DEVICES MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 C. R. Bard, Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Becton, Dickinson and Company
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Cook Group Incorporated
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Devicor Medical Products, Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Argon Medical Devices, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 B. Braun Melsungen AG
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Cardinal Health, Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Olympus Corporation
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Boston Scientific Corporation
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 Fujifilm Holdings Corporation
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 Inrad, Inc.
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 Medtronic PLC
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

12 Appendix
12.1 Related Reports